About Course #N1751
Release Date: December 27, 2016
Expiration Date: December 31, 2019
Studies show that millions of people each year in the United States are affected by mental illness, however only about half of these receive treatment. Approximately 40 million people (18%) of the population suffer from an anxiety disorder annually. The prevalence of bipolar disorders is projected to be at 2.6% of the adult population and 11.2% for 13 to 18 year olds. Depressive conditions are among the most frequently occurring mental health disorders in this country, 6.6% of adults aged 18 or older had a major depressive episode in 2014. The lifetime prevalence of schizophrenia is calculated to be about 1% of the population.
With the growing number of nurse practitioners entering the healthcare field as primary care providers, there is a demonstrated need for education on the ever-increasing number of new pharmaceutical agents available, to treat the wide spectrum of mental illness. This course addresses these needs by providing up-to-date information and a variety of case studies to illustrate practical application of the learning content.
This course should not be taken in conjunction with course #N1692 Antidepressants, 2nd Edition, course #N1710 Differentiating Antipsychotics: An Overview of Properties Impacting Drug Selection, or course #N1713 Anxiolytics and traditional Mood Stabilizers.
Kentucky APRNs - fulfills pharmacology requirement
About the Author(s)
Charles F. Caley, BS Pharm, PharmD, BCPP, is Clinical Professor of Pharmacy Practice at the University of Connecticut School of Pharmacy and is a board-certified psychiatric pharmacist providing clinical and education services at the Institute of Living in Hartford, Connecticut. He received his BS in Pharmacy and PharmD degrees from the University of Rhode Island College of Pharmacy and then completed a 2-year specialty residency in psychiatric pharmacy at the Institute of Mental Health in Cranston, Rhode Island, and at Eastern State Hospital in Medical Lake, Washington. Dr. Caley is also an active provider of professional service to the psychiatric pharmacy profession.
Corey E. Scheer, RPh, BS Pharm, PharmD, BCPP, completed her BS Pharm and Doctor of Pharmacy degree at the University of Connecticut and then went on to complete a postgraduate year 1 residency at the University of Rochester Medical Center in Rochester, New York. From there, she completed a postgraduate year 2 residency specializing in psychiatric pharmacy at the Tuscaloosa VA Medical Center in Tuscaloosa, Alabama. After completing 2 years of residency, Dr. Scheer accepted a position as Clinical Assistant Professor of Pharmacy Practice at Western New England University College of Pharmacy.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.